Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384864 · ClinicalTrials.gov registry record · Early Phase 1
Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia
A Early Phase 1 study of Barrett's Esophagus and Intraepithelial Neoplasia, sponsored by Anandasabapathy, Sharmila, M.D..
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01384864 is a Early Phase 1 study of Barrett's Esophagus and Intraepithelial Neoplasia that has completed, run by Anandasabapathy, Sharmila, M.D.. The registered enrollment target is 30 participants, below the 523-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01384864, a Early Phase 1 study of Barrett's Esophagus and Intraepithelial Neoplasia, has completed, sponsored by Anandasabapathy, Sharmila, M.D..
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this pilot study is to determine whether multispectral imaging increases the diagnostic accuracy of the current standard of high-definition white-light endoscopy for the detection of Barrett's-associated neoplasia (high grade dysplasia or cancer). The investigators goal is to develop a multispectral endoscopic platform that can be used to survey a large surface area and, potentially, serve as a 'red flag' for microendoscopic imaging of small areas. The goal of this pilot study is to preliminarily determine the accuracy of these modalities during the endoscopic surveillance of Barrett's esophagus.
Conditions Studied
Interventions
- DRUG proflavine
Study Locations (1)
New York
- Mount Sinai School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-08 |
| Est. Completion | 2015-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01384864
The ClinicalTrials.gov registry entry for NCT01384864 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 523-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (94% lower). The listed sponsor is Anandasabapathy, Sharmila, M.D., which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Barrett's Esophagus appearing as the primary indexed condition, and to 1 intervention - of which proflavine is the first listed.
NCT01384864 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01384864 about?
NCT01384864 is a clinical study titled "Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia". The overall objective of this pilot study is to determine whether multispectral imaging increases the diagnostic accuracy of the current standard of high-definition white-light endoscopy for the detection of Barrett's-associated neoplasia (high grade dysplasia or cancer). The investigators goal is t...
What is the current status of trial NCT01384864?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2011-08. Estimated completion is 2015-12.
What conditions does trial NCT01384864 study?
This clinical trial studies the following conditions: Barrett's Esophagus, Intraepithelial Neoplasia.
What interventions are being tested in trial NCT01384864?
The interventions under investigation include: proflavine (DRUG).
Who is sponsoring clinical trial NCT01384864?
This trial is sponsored by Anandasabapathy, Sharmila, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01384864 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
RECRUITING · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
-
Barrett's Esophagus Related Neoplasia (BERN) Project
RECRUITING
-
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING
-
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
RECRUITING
-
Navicam for Detection of Barrett's Esophagus
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.